openPR Logo
Press release

Coenzymes Q10 Market will reach at a CAGR of 9.2% from 2018 to 2028

08-02-2018 04:25 PM CET | Advertising, Media Consulting, Marketing Research

Press release from: Fact.MR

Coenzymes Q10 Market will reach at a CAGR of 9.2% from 2018 to 2028

Increasing penetration of coenzyme Q10 in cancer and Huntington’s disease treatment is creating new growth avenues for stakeholders. In addition to traditional applications in treating cognitive illnesses and cardiovascular diseases, demand for coenzyme Q10 is also complemented by growing adoption in cosmetics industry. The outlook on the global coenzyme Q10 market remains positive, with a 9.1% volume CAGR projected for the period between 2018 and 2028. Revenues from global sales of CoQ10 will reach approximately US$ 1,500 Mn by 2028-end.

Formulation Blending & Forward Integration to Remain Key Strategies Employed by Market Players

Merging of different formula for developing a more effective product to be a key focus area of CoQ10 manufacturers. The report further states that prominent stakeholders in the global coenzyme Q10 market are focusing on forward integration, in order to reduce supplier costs and yield profitability. Manufacturers who incorporate energy generating compounds and antioxidants such as CoQ10 in their dietary supplement products are set to account for larger shares of the market in the foreseeable future.

Ubiquinol Preferred Over Ubiquinone — Global Sales to Surpass US$ 800 Mn by 2028-end

End-users are showing a marked preference for ubiquinol, and it is likely that over the forecast period, value sales of ubiquinol are likely to outgrow those of ubiquinone. Over US$800 Mn worth of ubiquinol is envisaged to be sold worldwide by 2028-end. High rise of ubiquinol in the coenzyme Q10 market is attributed to its potential in curtailing production of oxidative stress by free radical damage linked with strenuous exercises.

Ubiquinol has also been witnessed to enhance the overall performance and power output in elite athletes. Despite similar effectiveness of ubiquinone as that of ubiquinol, the latter will gain more ground in the market on account of its better absorption capability.

Request Report Sample @ https://www.factmr.com/connectus/sample?flag=S&rep_id=732

Use of Microbial Fermentation Production Process Higher than Chemical Synthesis

Widespread adoption of coenzyme Q10 across cosmetic and pharmaceutical sectors has led to greater commercial interest in scaling up its production. Microbial fermentation continues to be the most effective production method for coenzyme Q10, with the advent of novel tools in the field of synthetic biology that offer new possibilities beyond traditional forms of metabolic engineering.

Chemical synthesis for production of CoQ10 is slightly losing traction on account of numerous costs involved such as in high energy catalysis reactions. In addition, this CoQ10 production methods further lacks stereoselectivity, which makes it difficult to segregate optimal isomers.

Nutraceuticals Industry to Latch onto Relatively Greater Value Share in CoQ10 Market

Comparatively greater value share has been envisaged for the nutraceuticals industry in the global CoQ10 market. High demand in this industrial sector can be attributed to growing adoption of nutraceutical supplements containing CoQ10 as an effective protection against heart diseases. Pharmaceuticals industry will also hold a major value share in the global coenzyme Q10 market, driven by its soaring application scope in treatment of cognitive diseases and eye care.

Request Report Methodology @ https://www.factmr.com/connectus/sample?flag=RM&rep_id=732

APEJ Continues to Spearhead CoQ10 Market in Terms of Value Sales

Led by emergence of SMEs coupled with increased usage of cosmetics in China and India, Asia-Pacific excluding Japan (APEJ) is foreseen to lead the global coenzyme Q10 market in terms of value sales in the near future. Favorable regulatory policies along with promising application outlook in personal care products will favor the CoQ10 market in APEJ.

About Fact.MR

Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.

Fact.MR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com
Web: https://www.factmr.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Coenzymes Q10 Market will reach at a CAGR of 9.2% from 2018 to 2028 here

News-ID: 1159843 • Views:

More Releases from Fact.MR

Hemoglobinopathy Market Forecast Growing at 8.3% CAGR to Reach $1.7 Billion by 2034
04-24-2024 | Health & Medicine
Fact.MR
Hemoglobinopathy Market Forecast Growing at 8.3% CAGR to Reach $1.7 Billion by 2 …
In 2024, the global hemoglobinopathy market (ヘモグロビン症市場) is estimated to be worth US$788.1 million, with a projected compound annual growth rate (CAGR) of 8.3% through 2034. By 2034, the market size is expected to exceed US$1,745.7 million. The rise of genetic testing has led to a significant shift in the hemoglobinopathy market towards personalized medication. Companies are leveraging this trend to develop tailored treatment plans based on each patient's DNA
Sales Forecast of Elder Care Product Market to Reach US$ 56.7 Billion by 2034 with a 6.7% CAGR
04-24-2024 | Health & Medicine
Fact.MR
Sales Forecast of Elder Care Product Market to Reach US$ 56.7 Billion by 2034 wi …
The global elder care product market (高齢者介護製品市場) is anticipated to reach a value of US$ 29,600.2 million by 2024 and is expected to exceed US$ 56,719.4 million by 2034. Sales of these products are forecasted to grow at a CAGR of 6.7% through 2034, driven by the growing trend of aging-in-place. This trend is fueling innovations in technology integration, wearable health devices, and personalized safety solutions. Increasing awareness about elder
Veterinary Oncology Market Predicts 12% CAGR Through 2033 With a US$ 800 Million
04-24-2024 | Health & Medicine
Fact.MR
Veterinary Oncology Market Predicts 12% CAGR Through 2033 With a US$ 800 Million
In 2023, the veterinary oncology market (獣医腫瘍学市場) was valued at US$ 260 million, and it's anticipated to reach US$ 800 million by the end of 2033, with a projected compound annual growth rate (CAGR) of 12% from 2023 to 2033. Veterinary oncology focuses on caring for pets diagnosed with cancer, with the goal of enhancing their overall quality of life. Cancer is the leading cause of mortality among companion animals,
Sales of Luxury Eyewear are forecasted to reach US$ 56 billion by 2033
Sales of Luxury Eyewear are forecasted to reach US$ 56 billion by 2033
According to Fact.MR, a trusted provider of market research and competitive intelligence, the global Luxury Eyewear Market was valued at US$ 40 billion in 2023. Projections suggest that by the conclusion of 2033, this market is anticipated to escalate to US$ 56 billion. Forecasts indicate a steady Compound Annual Growth Rate (CAGR) of 3.4% in the global demand for luxury eyewear from 2023 to 2033. The surge in luxury eyewear sales

All 5 Releases


More Releases for Q10

What's driving the Coenzyme Q10 (CoQ10) Market?
Global Coenzyme Q10 (CoQ10) Market size is expected to grow over USD 1.5 billion by 2024, owing to its favorable application overview for treating ailments such as cancer, Parkinson’s syndrome, cognitive illness, periodontal, kidney failure, neurological disease, cardiovascular disease, and Huntington’s disease. Industry growth is catalyzed by the use of coenzyme Q10 as a main constituent in the cosmetics industry, primarily owing to its antioxidant feature/property. Coenzyme Q10 supports the
Global Coenzyme Q10 Market 2018 - Haotian, ZMC, NHU
Apex Market Research, recently published a detailed market research study focused on the "Coenzyme Q10 Market" across the global, regional and country level. The report provides 360° analysis of "Coenzyme Q10 Market" from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global Coenzyme Q10 industry, and estimates the future trend of Coenzyme Q10 market
Coenzyme Q10 (CoQ10) Market worth $1bn by 2024
Coenzyme Q10 Market size is forecast to exceed USD 1 billion by 2024; according to a new research report by Global Market Insights, Inc. Positive trend towards increasing application scope for dietary supplements and medical treatment industry should drive Coenzyme Q10 market size. It is used in disease treatment such as mental disorders and cardiovascular ailments. Request for Sample Copy of this report @ https://www.gminsights.com/request-sample/detail/741 Asia Pacific, led by India and China
Coenzyme Q10 Market Estimated to Flourish by 2026
The market of Coenzyme Q10 is expected to witness modest growth in the coming years. High medicinal value of Coenzyme Q10 coupled with its increasing demand in the cosmetic applications, such as sunscreen lotions and anti-ageing creams are expected to drive the growth of global coenzyme Q10 market. Additionally, its high growth can be attributed to various macro-economic factors such as growing geriatric population, recovered GDP, increased disposable income, increasing
PMR - Coenzyme Q10 Market : Global Snapshot by 2026
The market of Coenzyme Q10 is expected to witness modest growth in the coming years. High medicinal value of Coenzyme Q10 coupled with its increasing demand in the cosmetic applications, such as sunscreen lotions and anti-ageing creams are expected to drive the growth of global coenzyme Q10 market. Additionally, its high growth can be attributed to various macro-economic factors such as growing geriatric population, recovered GDP, increased disposable income, increasing
Emerging Demand of Coenzyme Q10 Market 2026
The market of Coenzyme Q10 is expected to witness modest growth in the coming years. High medicinal value of Coenzyme Q10 coupled with its increasing demand in the cosmetic applications, such as sunscreen lotions and anti-ageing creams are expected to drive the growth of global coenzyme Q10 market. Additionally, its high growth can be attributed to various macro-economic factors such as growing geriatric population, recovered GDP, increased disposable income, increasing